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Abstract: 
Aims 
To explore the feasibility and efficacy of home-based, computerised, cognitive 
rehabilitation in patients with multiple sclerosis using neuropsychological assessment 
and advanced structural and functional magnetic resonance imaging (fMRI). 
 
Methods 
38 patients with MS and evidence of cognitive impairment on the Brief International 
Cognitive Assessment for MS (BICAMS) were enrolled into the study. Patients were 
randomly assigned to undergo 45-minutes of computerised cognitive rehabilitation 
using RehaCom software (n = 19) three times weekly for six weeks or to a control 
condition (natural history DVDs, n = 19). 
 
Neuropsychological and MRI data were obtained at baseline (time 1), following the 6-
week intervention period (time 2) and after a further twelve weeks (time 3). Cortical 
activations were explored using a visual n-back fMRI paradigm and microstructural 
changes were explored using quantitative magnetisation transfer imaging (QMT).   
 
Results  
Overall,  88.9% of patients (16/18) in the intervention group completed at least 75% of 
the prescribed sessions. Compared to time 1, the treatment group showed a 
significantly greater improvement in SDMT gain scores between baseline and early 
follow up (time 2) compared to the control group (p = .005).  
 
The treatment group exhibited significantly increased activation in the bilateral 
prefrontal cortex and right temporoparietal regions relative to control group at time 3 
(p<0.05 FWE corrected). No significant changes were observed on QMT.  
 
Conclusion 
This study supports the hypothesis that home-based, computerised, cognitive 
rehabilitation may be a feasible and effective approach to improving cognitive 
performance in patients with MS. 
Clinical trials registration:  ISRCTN 54901925 
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Introduction: 
Cognitive impairment is present in 40-65% of individuals with MS (1). Studies have 
shown cognitive deficits, (in particular deficits in information processing speed, 
concentration and working memory) to be present in the early stages of MS (2-4).  
Cognitive impairment has a negative impact on quality of life (QOL) independent of 
physical symptoms (5, 6).  
 
There exists mounting evidence for neuroplasticity as a mechanism to compensate for 
accumulating pathology in MS and some tentative evidence that cognitive rehabilitation 
may be effective in preserving or improving cognitive function in patients with MS (7-
9). Computer-assisted cognitive rehabilitation has the potential to provide a structured 
and standardised approach to rehabilitation. RehaCom is one particular type of 
software designed and utilised for treatment of cognitive impairment in a number of 
disease states such as stroke, brain injury and psychiatric disorders (10, 11). It has been 
used in a growing number of trials of cognitive rehabilitation in MS as a more 
standardised intervention (8, 9, 12, 13). The difficulty level of the computerised tasks 
adapts to an individual’s performance, only increasing in difficulty in response to 
improving performance.  
 
Few studies have examined the structural basis of cognitive rehabilitation and 
longitudinal studies are relatively lacking (8, 14, 15). Animal data suggest that 
myelination is, at least in part, regulated by neuronal activity (16).  It is therefore 
conceivable that techniques, such as magnetisation transfer (MT), which is sensitive to 
myelin content, might be sensitive to structural plasticity in MS (17).  
 
In this study we combined neuropsychological assessment, functional MRI (fMRI) and 
quantitative magnetisation transfer imaging (QMT) to explore whether home-based, 
computerised cognitive rehabilitation is an effective means of promoting cognitive 
rehabilitation and whether the structural basis for rehabilitation can be better defined 
(18). The primary outcome of the study was measured as any improvement in cognition 
after the training, while the secondary outcomes included changes in fMRI, fatigue and 
quality of life assessments. 
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Subjects and Method 
 
Participants  
Thirty-eight patients with objective evidence of cognitive impairment were invited to 
participate in this study between February 2014 and February 2015. All participants 
signed informed written consent before undergoing testing. Inclusion criteria were as 
follows: (a) age between 18 and 65, (b) clinically definite MS, according to the McDonald 
criteria (19) (c) Expanded Disability Status Scale (EDSS) ≤6.5 (d) cognitive impairment 
as defined as scores below the 5th percentile for normative data (adjusted for age, sex 
and years of formal education (20) on one or more of the BICAMS tests.  
 
Patients were excluded if they had a history of significant psychiatric disorders, alcohol 
or substance abuse, visual acuity less than 6/18 corrected, oscillopsia or diplopia that 
would interfere with testing. Patients were also excluded if they had a MS relapse, 
received corticosteroids, or had changes made to psychoactive medications within the 
previous month.  
 
The study was approved by the Northern Ireland Research Ethics Committee. 
 
Study Design 
An open-design, randomised, controlled trial was conducted. Neuropsychological and 
MRI data were obtained at baseline (time 1), immediately following a 6-week 
intervention period (time 2) and after an additional 12 week follow-up period (time 3), 
during which time no additional intervention was administered (supplementary figure 
1).  
 
It was not possible for the cognitive assessments to be completed by a blinded assessor. 
The MRI analysis was conducted by a researcher blind to the patients’ group allocation. 
  
  5 
Cognitive and Behavioural Assessments 
At entry all participants underwent a detailed clinical neurological assessment including 
EDSS conducted by an experienced neurologist. Patients were screened for cognitive 
impairment using the Brief International Cognitive Assessment for MS (BICAMS). 
BICAMS is a brief (15-minute) screening tool to identify cognitive impairment in 
patients with MS and comprises the first five learning trials of the California Verbal 
Learning Test II (CVLT-II), the first three recall trials Brief Visuospatial Memory Test 
Revised (BVMT-R) and the Symbol Digits Modalities Test (SDMT) (21).  
 
The BICAMS assessment was conducted by a neurology clinical fellow with almost ten 
years clinical experience (J.C). The assessing neurologist was trained in BICAMS 
assessing methods by an experienced neuropsychologist (D.L). 
 
At baseline participants also completed a number of behavioural and QOL assessments 
including; 
 
EuroQOL five dimension questionnaire (EQ-5D), a generic health-related quality of life 
scale (22), Functional Assessment of MS (FAMS) (a MS specific quality of life scale) (23), 
Patient Activation Measure (PAM-13) (a 13 item generic scale for chronic illness 
management), and a measure of patient “empowerment” in MS (24), Unidimensional 
Self-Efficacy scale for MS (USE-MS) (25), the Hospital Anxiety and Depression Scale 
(HADS) (26), Multiple Sclerosis Neuropsychological Questionnaire (MSNQ) self-report 
(a patient self-reported measure of cognitive function) (27), and the Fatigue Severity  
Scale (28). 
 
At each subsequent time point participants underwent repeat cognitive assessment 
using BICAMS (same test forms) as well as repeat behavioural and QOL assessments.  
 
Randomisation 
Following baseline MRI, patients were randomised to either the treatment or control 
groups. Randomisation was performed using a random number generator and 
allocations were placed inside sealed folders. Folders were opened following baseline 
MRI.   
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Intervention 
The treatment group underwent six weeks of home-based, computer-assisted cognitive 
rehabilitation using RehaCom software (http://www.fixxl.co.uk). This consisted of 45-
minute sessions, three times weekly. The control group were asked to watch a series of 
natural history DVDs of corresponding duration and frequency to the rehabilitation 
sessions performed by the treatment group for six weeks. The need to evaluate MRI 
parameters in studies with active control conditions has been highlighted (15). 
 
Treatment sessions consisted of training in three specific modules involving working 
memory, visuospatial memory and divided attention. In all tasks the level of difficulty is 
tailored to the individuals performance and increases automatically but only in line 
with satisfactory progress. Real-time data pertaining to performance, progress and 
compliance is transmitted to the investigator over the Internet during the intervention 
period.  
 
“Divided attention” module 
In the divided attention task the patient is asked to drive a simulated car using 
keyboard inputs. Multiple distractions must be navigated and the speed and direction of 
the vehicle altered according to road conditions. As the complexity of the task increases 
more distractors are introduced with increased multitasking skills required. 
 
“Working memory” module 
The working memory task consists of remembering a series of playing cards presented 
briefly on screen. The participant is then asked to select which cards were presented 
from a longer series of options including distractor cards. As the complexity of the task 
increases participants are asked to remember only cards of a particular value or suit 
and the number of items to remember increases. Higher levels involve having to 
remember the cards in reverse order.   
 
“Topological memory” module 
Visuospatial memory is a similar task involving various objects presented briefly on 
screen with the patient asked to remember the object as well as its position in the 
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sequence. As the complexity of the task increases the number of items on screen 
increases and more abstract shapes are introduced.    
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MRI Imaging Protocol  
The following sequences were acquired in an order designed to minimise the potential 
for fatigue on the fMRI task: 1) Dual-echo Turbo spin-echo for lesion identification; 2) 
high-resolution T1-weighted magnetization-prepared rapid-acquisition gradient echo 
(MPRAGE); 3) functional MRI with echo-planar imaging (EPI) acquired during a n-
visually presented back task; (4) quantitative magnetization transfer (QMT) with 
balanced steady-state free precession (bSSFP) (29). 
 
T2 lesion volume was measured at baseline for each participant using the software 
package JIM (Version 3.0, Xinapse Systems Ltd., Northants, UK, 
http://www.xinapse.com). 
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N-back task 
A visual n-back test was presented during functional imaging acquisition. This was 
adapted from Sweet et al (30) and involved three conditions; 0-back, 1-back and 2-back 
tasks. The 0-back condition was designed to act as the baseline condition and would 
provide the baseline activation for comparison in fMRI analysis. The 1-back and 2-back 
conditions provided increasing working memory demands.  
 
The n-back task did not constitute part of the cognitive rehabilitation. All participants 
were allowed to briefly practice the n-back task under supervision for five minutes 
prior to the MRI scan to ensure comprehension of the task and allow familiarity with it. 
 
The visual n-back task was presented using Cogent V and MATLAB 2013a. Stimuli were 
projected onto a mirrored screen inside the MRI scanner 45cm from a participants nose. 
An MRI compatible button box was placed in the participant’s right hand. 
 
White letters were projected onto a black background in bold size 200 Arial font. This 
involved of a series of pseudo-randomised consonants in both upper and lower case. 
The stimulus duration was 1000ms with a between stimulus interval of 2000ms. 
Instructions were presented for 3000ms before each new n-back task.  
 
fMRI data were acquired during three 9-minute runs. 0-back, 1-back and 2-back tasks 
were presented in a randomised manner resulting in six blocks per nine minute run. 
Each block consisted of 126 stimuli, one third of which were targets. Twice as many 0-
back tasks were presented as 1-back or 2-back. There was a rest period of 90 seconds 
between blocks.  
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Statistical Analysis  
The primary outcome was cognitive performance as measured by improvement in 
SDMT, BVMT, CVLT between groups compared to baseline.  Secondary outcomes were 
QOL, fMRI and QMT measures as detailed below.    
 
(i) Behavioural data 
Descriptive statistics for normally distributed continuous variables are expressed as 
mean and standard deviation. Skewed continuous variables were summarised using 
median and interquartile range (IQR). Categorical variables are summarised by 
frequencies and percentages.  
 
Normality of continuous variables was assessed using the Kolmogorov-Smirnov test.  
 
Baseline cognitive and behavioural measures were compared between the treatment 
and control groups. Categorical variables were compared by the Pearson 2 test. The 
means of continuous variables were compared using the independent samples t-test or 
the Mann-Whitney U test for skewed data.   
 
All tests were two-tailed; p-values less than 0.05 were considered significant. 
 
Outcomes were compared between the two groups using independent samples t-test to 
compare gain scores for cognitive data between groups. To compare differences 
between groups for other behavioural and QOL data, a 2 x3 repeat measures analysis of 
variance (ANOVA) was used with “time” as the within subject factor and “treatment” as 
the between factor (active rehabilitation vs control). 
Analyses were performed using SPSS version 21 (Armonk, NY: IBM Corp).     
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(ii) Functional MRI analysis 
fMRI data were analysed using SPM8 (Wellcome Department of Cognitive Neurology, 
UCL, London, http://www.fil.ion.ucl.ac.uk/spm). 
 
For each time series, the first five EPIs were discarded to ensure steady state 
magnetisation. Individual EPIs were then realigned to the first remaining image of the 
series by rigid body transformation to correct for involuntary head movements during 
acquisition before normalisation into a standard anatomical space (Montreal 
Neurological Institute [MNI]) using linear and non-linear transformations. Finally, 
images were smoothed with an 8mm3 full-width-at-half-maximum (FWHM) 3D 
Gaussian kernel.  
 
First-Level Analysis 
For each participant, the difference in blood oxygen level-dependent (BOLD) response 
between the 0-back, 1-back and 2-back conditions was estimated at every voxel across 
the whole brain using the general linear model (GLM). This produced a series of 
contrasts representing mean activation during each n-back condition minus the 0-back 
condition. 
 
Second-Level Analysis 
Each contrast obtained at the first-level was entered into a second level GLM to 
generate summary statistical parametric maps (SPMs). For between group analysis of 
difference between the time points, we used a 3 x 2 ANOVA flexible factorial design with 
group (between-subject) and time (within-subject) as separate factors to examine the 
main effects on group (treatment versus control), time and the interaction between 
them to evaluate areas of relative change in activity after cognitive training versus 
control. 
 
The threshold for significance was set at an alpha of 0.05 corrected for multiple 
comparisons (family-wise error (FWE) corrected).Results are reported at cluster level 
throughout . Within each region of statistical significance, the location of local maxima 
of signal intensity increase is expressed as x, y, and z coordinates in MNI space.  
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(iii) Quantitative MT analysis 
The MT data were analysed using SPM8. MT and T1 mapping data from all three 
sessions were first realigned to subject specific MPRAGE structural images using the 
SPM8 rigid-body registration function. The MPRAGE were then segmented into white 
matter, grey matter and CSF to yield a parenchymal mask.  
A T1 map was calculated for all datasets by fitting the theoretical spoiled gradient echo 
as a function of the flip angle to the signal measured by the 3D FLASH sequences (31). 
MT parameters were obtained by performing a voxel wise non-linear least squares 
fitting (Levenberg–Marquardt) to a binary spin bath model for bSSFP.  
The statistical analysis was performed voxel-wise in SPM8 on the resulting warped and 
smoothed MT maps. The same GLMs used for the second level fMRI analysis and 
described in the previous section were used for estimating the main effects of time and 
group and the interaction between these two factors. 
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Results  
Baseline characteristics 
38 patients were included in the study. The majority of the participants were female 
(71.1%). At entry 27 patients (70.3%) had RRMS, and 11 patients (29.7%) had SPMS. 
Patients were aged between 32 and 62 (mean 47.37, SD 8.23). The duration of MS from 
diagnosis to enrolment ranged from 12 months to 40 years  (mean 11.61 years, SD +/- 
8.2 yrs). Median EDSS was 5.0 (3.5 – 6.0). 20 patients (52.6%) were on disease 
modifying therapy at enrolment (natalizumab n=6, beta-Interferon n=7, fingolimod n=6 
and teriflunomide n=1).  
 
After randomisation to either computer-assisted cognitive training (treatment group, 
n=19) or the active control condition (n=19), there were no significant differences in 
terms of baseline demographics (table 1) or quality of life measures (supplementary 
table 3) between the two groups.  
The treatment group had higher baseline cognitive scores on the BICAMS battery 
however these did not differ significantly from the control group.  
 
The most frequently failed component of the BICAMS test battery was the SDMT with 33 
(86.8%) of participants scoring below the 5th centile, 18 (47.4%) failed the CVLT-II and 
13 (34.2%) failed the BVMT-R. Overall 21(55.2%) failed one test, 10 (26.3%) failed two 
tests and 7 (18.4%) failed all three tests of the BICAMS test battery. This level of 
impairment is consistent with other published MS samples on BICAMS (32-34). 
 
Overall,  88.9% of patients (16/18) in the intervention group completed at least 75% of 
the prescribed sessions with 66.7% (12/18) completing all the prescribed sessions.  
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Table 1: Baseline Demographic Characteristics and Cognitive Performance 
 Treatment group  
(n=19) 
Control group  
(n=19) 
  
 Mean (SD) Mean (SD) Mean difference (95% CI) p 
Age (years) 46.21 (6.59) 48.53 (9.63) -2.31 (-7.75 to 3.12) .588 
Disease duration (years) 10.53 (6.13) 12.68 (9.87) -2.16 (-7.56 to 3.25) .424 
EDSS 4.42 (1.75) 4.45 (1.77) -0.26 (-1.18 to 1.13) .964 
Education (years) 14.05 (2.76) 13.63 (2.89) 0.42 (-1.43 to 2.28)  .649 
SDMT 43.39 (7.39) 38.21 (11.39) 5.18 (-1.27 to 11.63) .112 
CLVT 45.32 (9.56) 43.89 (9.73) 1.42 (-4.93 to 7.77) .653 
BVMT 20.63 (5.77) 18.05 (7.37) 2.58 (-1.77 to 6.93) .237 
 
 N/19 (%)  N/19 (%)  Odds ratio (95% CI) p 
Gender (female) 13      (68.4) 14   (73.6) 0.74 (0.19 to 3.15) .721 
Unemployed  13      (68.4) 11   (57.9) 1.58 (0.42 to 5.95) .501 
Disease subtype: 
     Relapsing-remitting  
     Secondary-progressive  
 
14      (73.6) 
5         (26.3) 
 
13   (68.4) 
6     (31.6) 
 
1.29 (0.32 to 5.28) 
 
.721 
 On treatment at enrolment  
      Interferon * 
      Fingolimod   
      Natalizumab 
      Teriflunomide 
12       (63.2) 
 
5 
5 
2 
0 
8     (42.1) 
 
2 
1 
4 
1 
2.38 (0.64 to 8.68) .194 
*Includes Interferon (IF)-1b SC, IF-1A IM and IF-1A SC 
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Behavioural outcomes  
The main behavioural outcomes are shown in table 2.  
 
Time 2 vs Time 1 
Compared to time 1, the treatment group showed a significantly greater improvement 
in gain scores between baseline and early follow up (time 2) compared to the control 
group on the SDMT [treatment 3.94 (SD 5.08), controls -0.63 (SD 3.30), 1.47 to 7.66, 
(95% CI 1.47 to 7.66), p = .005] and illustrated in figure 1. 
 
Similar gain scores in the CVLT and BVMT-R were not significantly different between 
the groups although the BVMT-R gain scores did approach significance (p =.098).  
 
Cognitive outcomes - Time 3 vs Time 1 
Overall, there was an improvement in BICAMS performance across participants at 
follow up. The gain scores between the groups at time 3 compared to baseline were, 
however, not statistically significantly different.  
 
QOL outcomes 
At time 2 and time 3 there were no significant differences in QOL outcome measures, 
measures of self-efficacy or subjective cognitive performance between the two groups 
(supplementary table 4). 
 
N-back outcomes 
The baseline error rate between the treatment and control groups was low (8.64% vs 
9.48%, p = 0.814). No significant differences were observed in the error rate during the 
n-back task between the groups at baseline or at follow-up (supplementary table 5).  
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Table 2: BICAMS outcomes in Treatment versus Control Groups  
BICAMS improvement at follow up (time 2 vs time 1) 
 Treatment (n=17) 
Mean (SD) 
Control (n=18) 
Mean (SD) 
Mean 
difference 
95% CI p 
SDMT gain  3.94 (5.08) -0.63 (3.30) 4.56 1.47 to 7.66 .005 
CVLT gain   6.67 (7.56) 4.06 (10.10) 2.71 -3.45 to 8.87 .377 
BVMT gain   4.65 (5.18) 1.94 (4.17) 2.70 -0.52 to 5.93 .098 
BICAMS improvement at follow up (time 3 vs time 1) 
 Treatment (n=17) 
Mean (SD) 
Control (n=14) 
Mean (SD) 
Mean 
difference 
95% CI p 
SDMT gain 3.35 (4.17) 4.57 (7.21) -1.28 -5.45 to 3.01 .582 
CVLT gain  6.94 (7.01) 7.50 (8.83) -0.56 -6.38 to 5.26 .849 
BVMT gain  7.29 (5.07) 4.14 (5.32) 3.15 -0.68 to 6.98 .105 
SDMT: Symbol Digits Modalities Test; CVLT: California Verbal Learning Test; BVMT: Brief Visuospatial Memory Test. 
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Figure 1: Improvement in SDMT slope immediately post-intervention 
 
 
 
Proportion of patients showing greater than 10% improvement in SDMT immediately 
post-intervention by group. 
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Functional MRI 
Baseline: Main effect of task 
The n-back task was associated with robust activations of several cortical areas. The 1-
back task was associated with activations involving the dorsolateral prefrontal cortex 
bilaterally as well as bilateral inferior parietal lobule, insular and cerebellar regions 
relative to the 0-back contrast. The same regions were activated in the 2-back condition 
but the spatial extent and magnitude of the responses was greater, particularly over the 
fronto-parietal regions (supplementary figure 2 and supplementary table 2). 
 
Time 2 vs Time 1 
At time 2, increased activation was seen in the right temporo-parietal regions (right 
supramarginal and angular gyri (p<0.005FWE corrected at cluster level (k=228).) in the 1-
back in the treatment group relative to controls (group-by-time interaction). No 
significant change was seen in the 2-back task.  
 
Time 3  
At time 3 significant increases in activation were seen in both the 1-back and 2-back 
conditions in the treatment group relative to controls. In the 1-back task, increased 
activation was seen in the left frontal (p<0.001FWE corrected at cluster level (k=294) and 
right temporo-parietal regions (p<0.012FWE corrected at cluster level (k=187). In the 2-back 
task, increases in activation were seen in bilateral prefrontal (p<0.013FWE corrected at 
cluster level (k=206)  and right temporo-pariteal regions (p<0.024 FWE corrected at cluster 
level (k=178)  (figure 1). 
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Figure 2: Increased activations in treatment group relative to controls at follow up  
 
Quantitative Magnetisation Transfer 
No significant between-group changes were seen in the QMT at time 2 or time 3, with 
respect to time 1. Overall QMT measures showed stability across all participants over 
the course of the study in measures of all indices.  
(A) Increased activation in treatment group in right parietal region (white arrow, 
p<0.012FWE corrected) and left prefrontal region (dashed arrow, p <0.001 FWE corrected).  
 
(B)Bilateral frontal gyrus activation in treatment group relative to controls. Left MFG 
activation (arrow) significant at p = <0.042 FWE-corrected at cluster level (k=152). 
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Discussion 
In line with previous work (8), the main outcome of this study was that 6 weeks of 
computerised cognitive rehabilitation was associated with improvement in cognitive 
performance as measured on the SDMT. Significant alterations in brain fMRI activations 
during the n-back task were also seen at follow up. The SDMT improvement in the 
treatment group was however, not maintained after cessation of cognitive rehabilitation 
(time 3 assessments) although the functional MRI changes were seen to persist at 
follow-up.  
 
The SDMT is among the most sensitive tests of slowed information processing speed in 
MS (35, 36) and may also be a proxy for general cognitive impairment (37). Compared 
to time 1, the treatment group showed a significantly greater improvement in gain 
scores between baseline and early follow up (time 2) compared to the control group on 
the SDMT (p = .005). However, the gain scores between the groups at time 3 compared 
to baseline were not statistically significantly different. Overall, there was an 
improvement in BICAMS performance across participants at follow up. It may be the 
case that cognitive rehabilitation does indeed result in improved cognitive performance 
but that maintainence of such improvement requires some form of ongoing intervention 
in the longer term. The optimum frequency and duration of cognitive training therefore 
remains unclear.  
 
Clearly, repeat testing is potentially associated with practice effects. This may be 
particularly problematic when using the same form of a test. Only one version of the 
BICAMS test battery has been validated in MS and was thus was used in this study. 
Reported test-retest coefficients on the BICAMS tests are excellent, suggesting practise 
effects are negligible (32, 34). In addition, the experimental design was to compare two 
groups with identical testing schedules, therefore the impact of practise effects on the 
results are likely to be minimal. 
 
QOL measures did not differ significantly between groups.  QOL is a complex construct 
influenced by a multitude of factors such as employment status, social networks, 
perceptions of self-worth and self-efficacy. It is possible that cognitive rehabilitation has 
a positive impact on a number of these factors but such changes in such factors may 
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take time to manifest as improvements in QOL. Further longitudinal analysis may be 
required to investigate this.  
 
In order to minimise practice effects associated with repeat testing participants were 
not directly trained in the n-back task, rather it was utilised as an outcome measure of 
working memory. It was anticipated that if cognitive rehabilitation was effective at 
improving working memory and attention then the effects would be reflected on the 
performance on the n-back task.  No differences were seen in the error rate between the 
groups during the n-back task at follow up however the error rate was low at baseline 
in both groups.  
 
The n-back fMRI paradigm in our study cohort was however, associated with robust 
baseline cortical activations (in particular within the DLPFC and posterior parietal 
cortex) in keeping with known working memory networks (38). A significant group-by-
time interaction was seen with the treatment group exhibiting increased activation in 
the bilateral prefrontal cortex and right temporoparietal regions relative to control 
group at time 3 (p<0.05 FWEcorr).  
 
Changes in functional activation within these regions within the treatment group are 
felt to be functionally relevant with respect to cognitive rehabilitation. It has been 
shown that the prefrontal cortex is critical in the executive control of working memory 
and has a role in response inhibition (39, 40). Effective organisation of working memory 
may attenuate task difficulty resulting in improved working memory performance (39).  
 
A right hemisphere dominant “ventral attentional network” consisting of the temporo-
parietal junction, ventral prefrontal cortex and anterior insula is thought to be 
responsible for directing attention to salient events (41). Previous work in MS has 
indicated that attention may be one of the domains most amenable to rehabilitation (8). 
Many of the computer-training tasks involve sustained attention and it might be 
postulated that the increased activation seen in the right temporo-partietal region at 
follow-up in the treatment group is as a result of improved efficiency of this network.  
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Interestingly, the evolution of much activity on fMRI developed after cessation of the 
active intervention phase. It is likely the case that solidification of neural networks 
occurs with training. This solidification of neural networks may extend to 
areas/networks outside those directly trained and may explain why working memory 
centres such as the prefrontal cortex were seen to be persistently active after cessation 
of formal training (42). Debate remains however as to the possible interplay between 
adaptive and maladaptive responses during functional brain reorganisation (15). 
 
The discrepancy between the apparent lack of clinical difference between the groups at 
time 3 and the sustained fMRI effect at time 3, may reflect the fact that BICAMS does not 
adequately measure working memory which is primary domain utilised during the n-
back fMRI paradigm. 
 
Some studies have identified structural changes on diffusion tensor imaging as a result 
of rehabilitation in the context of physiotherapy (43, 44). Our study attempted to 
explore the role of myelin in rehabilitation and repair. We did not detect any structural 
change on QMT after training. Due to the short duration of follow up, this is not entirely 
surprising. Functional alterations in cortical activity may subsequently modulate brain 
structure at the microstructural level but such changes in structural brain architecture 
might only be detectable over the longer term.  
 
In contrast to many previous studies, which often rely on one-to-one or outpatient 
administered cognitive rehabilitation, this study sought to explore whether a home-
based approach to cognitive rehabilitation was feasible. The compliance rate of those 
undertaking the rehabilitation was excellent. A home-based approach to cognitive 
rehabilitation is significantly less resource intensive and may pave the way to greater 
access for a greater number of patients to such interventions in the future.  
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Limitations 
This work has some limitations. Firstly, the groups were relatively small and there was 
a dropout of patients mainly in the control group between time 2 and time 3.  There was 
heterogeneity with regards to the cognitive domains that showed deficits among 
participants in the study. It is likely therefore that they may not have benefited from the 
rehabilitation in the same way. Unfortunately the sample size of the study is too small to 
perform subgroup analysis. 
 
As the study was largely exploratory in nature, it utilised an open design and is 
therefore subject to a number of limitations inherent to this type of design. For 
pragmatic reasons blinding of the investigating neurologist was not established due to 
the potential need for interaction between patient and investigator, This does present 
the potential for observer bias, particularly where repeat testing is required.  
 
SPM analysis of MRI data offers objective, largely automated measures, which are 
independent of measurement bias. Investigator blinding was maintained for any 
methods such as assessment of white matter lesion volumes that involved manual 
interpretation. 
 
In many respects, the SDMT may provide a proxy for overall cognitive functioning (45) 
but a more detailed cognitive assessment of the domains directly trained may have 
provided additional insight into effectiveness of cognitive training. BICAMS is primarily 
designed as a screening tool for cognitive impairment in MS assessing a limited number 
of domains. However strong ecological validity has been demonstrated in relation to 
everyday task performance and employment, suggesting that the three domains are 
strongly predictive of comprehensive real-world performance (46, 47). BICAMS may 
not necessarily be sensitive to change over the short-term, although the reported test-
retest coefficients are excellent which would suggest sensitivity over this period (32, 34, 
48).  
 
It is postulated that alterations in fMRI activity result from microstructural changes. The 
lack of significant change in QMT measurements however, suggests that the 
microstructural changes thought to underpin adaptive responses, may, at present, be 
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beyond the resolution of even the most advanced MRI techniques or not manifest within 
the timescale of this study. Additional follow-up of this cohort is planned to determine 
what, if any, changes are observed both in terms of cortical activation as measured by 
fMRI and structural changes measurable with QMT. Longer-term studies may also 
provide insight into the true functional impact of cognitive rehabilitation such as 
maintenance of employment. 
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